About Reflux Pharmaceuticals
Reflux Pharmaceuticals is a company based in Navi Mumbai (India) founded in 2020. Reflux Pharmaceuticals offers products and services including Tolfenamic Acid and Flavoxate HCl.
- Headquarter Navi Mumbai, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Reflux Pharmaceuticals Private Limited
- Date of Incorporation 03 Feb, 2020
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$2.14 M (USD)386.06as on Mar 31, 2022
-
Net Profit
$31.63 K (USD)-5.71as on Mar 31, 2022
-
EBITDA
$58.71 K (USD)16.11as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reflux Pharmaceuticals
Reflux Pharmaceuticals offers a comprehensive portfolio of products and services, including Tolfenamic Acid and Flavoxate HCl.
Tolfenamic Acid is produced as a non-steroidal anti-inflammatory drug for pharmaceutical applications.
Flavoxate HCl is manufactured for anti-spasmodic uses and treatment of urinary incontinence.
Funding Insights of Reflux Pharmaceuticals
Investors in Reflux Pharmaceuticals
Reflux Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Eiko LifeSciences Limited.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturing and exporting of speciality chemicals and pharma intermediates in India.
|
Locked | Locked | Locked |
Investor details for Reflux Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reflux Pharmaceuticals
Investment portfolio details for Reflux Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reflux Pharmaceuticals
Detailed financials for Reflux Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reflux Pharmaceuticals Comparisons
Peer comparison for Reflux Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reflux Pharmaceuticals
Detailed competitors of Reflux Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reflux Pharmaceuticals
Complete news archive for Reflux Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reflux Pharmaceuticals
Reflux Pharmaceuticals was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Reflux Pharmaceuticals is headquartered in Navi Mumbai, India. It is registered at Navi Mumbai, Maharashtra, India.
Annual revenue of Reflux Pharmaceuticals is $2.14M as on Mar 31, 2022.
Reflux Pharmaceuticals was established in 2020 and is based in Navi Mumbai, India. The company operates within the pharmaceutical sector, focusing on the production of active pharmaceutical ingredients (APIs) and chemical intermediates. These materials are supplied to support drug manufacturing processes. Operations emphasize quality-controlled synthesis and formulation, serving clients in the global healthcare industry. The firms activities align with regulatory standards for pharmaceutical components.
Reflux Pharmaceuticals offers Tolfenamic Acid and Flavoxate HCl.
Reflux Pharmaceuticals has 1 investor. Key investors include Eiko LifeSciences Limited.